Singapore - English - HSA (Health Sciences Authority)

becton dickinson medical (s) pte ltd - general hospital - intended to be inserted into a patient’s peripheral vascular system for short term use to sample blood, monitor blood pressure, or administer fluids. these catheters may be used for any patient population with consideration given to adequacy of vascular anatomy, procedure being performed, fluids being infused, and duration of therapy.

United States - English - NLM (National Library of Medicine)

athena bioscience, llc - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - nexiclon xr is indicated in the treatment of hypertension. nexiclon xr may be employed alone or concomitantly with other antihypertensive agents. nexiclon xr should not be used in patients with known hypersensitivity to clonidine [ see  warnings and precautions (5.2) ]. pregnancy category c. reproduction studies performed in rabbits at doses up to approximately 3 times the oral maximum recommended daily human dose (mrdhd) of clonidine hydrochloride produced no evidence of a teratogenic or embryotoxic potential in rabbits. in rats, however, doses as low as 1/3 the oral mrdhd (1/15 the mrdhd on a mg/m 2 basis) of clonidine were associated with increased resorptions in a study in which dams were treated continuously from 2 months prior to mating. increased resorptions were not associated with treatment at the same time or at higher dose levels (up to 3 times the oral mrdhd) when the dams were treated on gestation days 6 to 15. increases in resorption were observed at much higher dose l

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - dronedarone - atrial fibrillation - cardiac therapy - multaq is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (af). due to its safety profile, multaq should only be prescribed after alternative treatment options have been considered.multaq should not be given to patients with left ventricular systolic dysfunction or to patients with current or previous episodes of heart failure.

United States - English - NLM (National Library of Medicine)

athena bioscience, llc - fenofibric acid (unii: bgf9mn2hu1) (fenofibric acid - unii:bgf9mn2hu1) - fibricor is indicated as adjunctive therapy to diet for treatment of severe hypertriglyceridemia (≥ 500 mg/dl). improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention. markedly elevated levels of serum triglycerides > 2000 mg/dl may increase the risk of developing pancreatitis. the effect of fenofibrate therapy on reducing this risk has not been adequately studied. fibricor is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides (tg), and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in patients with primary hypercholesterolemia or mixed dyslipidemia. fenofibrate at a dose equivalent to 105 mg of fibricor was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus [see warnings and precautions (5.1) ]. fibricor is contraindicated in: - pat

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - acetylsalicylic acid 75 mg bisoprolol fumarate 5 mg - beta blocking agents

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - acetylsalicylic acid 75 mg bisoprolol fumarate 10 mg - beta blocking agents

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - bisoprolol fumarate 5 mg acetylsalicylic acid 100 mg - beta blocking agents

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - bisoprolol fumarate 10 mg acetylsalicylic acid 100 mg - beta blocking agents

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - bisoprolol fumarate 5 mg acetylsalicylic acid 75 mg - beta blocking agents

Malta - English - Medicines Authority

athena pharmaceutiques sas 12 rue georges blandon 78430 louveciennes, france - hard capsule - bisoprolol fumarate 10 mg acetylsalicylic acid 75 mg - beta blocking agents